15-Lipoxygenase-mediated modification of high-density lipoproteins impairs SR-BI- and ABCA1-dependent cholesterol efflux from macrophages

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1761, Issue 3, 2006, Pages 292-300

  Pirillo, Angela ^a   Uboldi, Patrizia ^a   Kuhn, Hartmut ^b   Catapano, Alberico L ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

15 lipoxygenase; ATP binding cassette transporter A1; High density lipoprotein; Reverse cholesterol transport; Scavenger receptor class B, type I

Indexed keywords

ABC TRANSPORTER A1; APOPROTEIN; ARACHIDONATE 15 LIPOXYGENASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR BI;

ANIMAL CELL; ARTICLE; CATALYSIS; CHOLESTEROL TRANSPORT; ELECTRON; ENZYME BINDING; ENZYME MODIFICATION; HUMAN; MACROPHAGE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING;

ANIMALS; ARACHIDONATE 15-LIPOXYGENASE; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; CHOLESTEROL; HUMANS; LIPOPROTEINS, HDL; MACROPHAGES; MICE; RABBITS; SCAVENGER RECEPTORS, CLASS B; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA;

EID: 33646128719     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2006.03.009     Document Type: Article

References (53)

1. Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 110 (2002) 905-911
2. Osterud B., and Bjorklid E. Role of monocytes in atherogenesis. Physiol. Rev. 83 (2003) 1069-1112
3. von Eckardstein A., Nofer J.R., and Assmann G. Acceleration of reverse cholesterol transport. Curr. Opin. Cardiol. 15 (2000) 348-354
4. Sviridov D., and Nestel P. Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis 161 (2002) 245-254
5. von Eckardstein A., Nofer J.R., and Assmann G. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 13-27
6. Brewer Jr. H.B., Remaley A.T., Neufeld E.B., Basso F., and Joyce C. Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1755-1760
7. Yancey P.G., Bortnick A.E., Kellner-Weibel G., de la Llera-Moya M., Phillips M.C., and Rothblat G.H. Importance of different pathways of cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 712-719
8. Oram J.F. HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 720-727
9. Slotte J.P., and Gronberg L. Oxidation of cholesterol in low density and high density lipoproteins by cholesterol oxidase. J. Lipid Res. 31 (1990) 2235-2242
10. Lavy A., Brook G.J., Dankner G., Ben Amotz A., and Aviram M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 40 (1991) 794-799
11. Bradamante S., Barenghi L., Giudici G.A., and Vergani C. Free radicals promote modifications in plasma high-density lipoprotein: nuclear magnetic resonance analysis. Free Radic. Biol. Med. 12 (1992) 193-203
12. Musanti R., and Ghiselli G. Interaction of oxidized HDLs with J774-A1 macrophages causes intracellular accumulation of unesterified cholesterol. Arterioscler. Thromb. 13 (1993) 1334-1345
13. Hurtado I., Fiol C., Gracia V., and Caldu P. In vitro oxidised HDL exerts a cytotoxic effect on macrophages. Atherosclerosis 125 (1996) 39-46
14. Suc I., Brunet S., Mitchell G., Rivard G.E., and Levy E. Oxidative tyrosylation of high density lipoproteins impairs cholesterol efflux from mouse J774 macrophages: role of scavenger receptors, classes A and B. J. Cell Sci. 116 (2003) 89-99
15. Marsche G., Hammer A., Oskolkova O., Kozarsky K.F., Sattler W., and Malle E. Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport. J. Biol. Chem. 277 (2002) 32172-32179
16. Gesquiere L., Loreau N., and Blache D. Impaired cellular cholesterol efflux by oxysterol-enriched high density lipoproteins. Free Radic. Biol. Med. 23 (1997) 541-547
17. Rifici V.A., and Khachadurian A.K. Oxidation of high density lipoproteins: characterization and effects on cholesterol efflux from J774 macrophages. Biochim. Biophys. Acta 1299 (1996) 87-94
18. Nagano Y., Arai H., and Kita T. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 6457-6461
19. Hedrick C.C., Hassan K., Hough G.P., Yoo J.H., Simzar S., Quinto C.R., Kim S.M., Dooley A., Langi S., Hama S.Y., Navab M., Witztum J.L., and Fogelman A.M. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1946-1952
20. Bergt C., Pennathur S., Fu X., Byun J., O'Brien K., McDonald T.O., Singh P., Anantharamaiah G.M., Chait A., Brunzell J., Geary R.L., Oram J.F., and Heinecke J.W. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 13032-13037
21. Zheng L., Nukuna B., Brennan M.L., Sun M., Goormastic M., Settle M., Schmitt D., Fu X., Thomson L., Fox P.L., Ischiropoulos H., Smith J.D., Kinter M., and Hazen S.L. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J. Clin. Invest. 114 (2004) 529-541
22. Kuhn H., Belkner J., Suzuki H., and Yamamoto S. Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities. J. Lipid Res. 35 (1994) 1749-1759
23. Belkner J., Stender H., and Kuhn H. The rabbit 15-lipoxygenase preferentially oxygenates LDL cholesterol esters, and this reaction does not require vitamin E. J. Biol. Chem. 273 (1998) 23225-23232
24. Takahashi Y., Glasgow W.C., Suzuki H., Taketani Y., Yamamoto S., Anton M., Kuhn H., and Brash A.R. Investigation of the oxygenation of phospholipids by the porcine leukocyte and human platelet arachidonate 12-lipoxygenases. Eur. J. Biochem. 218 (1993) 165-171
25. Yla-Herttuala S., Rosenfeld M.E., Parthasarathy S., Glass C.K., Sigal E., Witztum J.L., and Steinberg D. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 6959-6963
26. Yla-Herttuala S., Rosenfeld M.E., Parthasarathy S., Sigal E., Sarkioja T., Witztum J.L., and Steinberg D. Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J. Clin. Invest. 87 (1991) 1146-1152
27. Kuhn H., Heydeck D., Hugou I., and Gniwotta C. In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J. Clin. Invest. 99 (1997) 888-893
28. Kuhn H., Belkner J., Zaiss S., Fahrenklemper T., and Wohlfeil S. Involvement of 15-lipoxygenase in early stages of atherogenesis. J. Exp. Med. 179 (1994) 1903-1911
29. Spanbroek R., Grabner R., Lotzer K., Hildner M., Urbach A., Ruhling K., Moos M.P., Kaiser B., Cohnert T.U., Wahlers T., Zieske A., Plenz G., Robenek H., Salbach P., Kuhn H., Radmark O., Samuelsson B., and Habenicht A.J. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1238-1243
30. Harats D., Shaish A., George J., Mulkins M., Kurihara H., Levkovitz H., and Sigal E. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2100-2105
31. Huo Y., Zhao L., Hyman M.C., Shashkin P., Harry B.L., Burcin T., Forlow S.B., Stark M.A., Smith D.F., Clarke S., Srinivasan S., Hedrick C.C., Pratico D., Witztum J.L., Nadler J.L., Funk C.D., and Ley K. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice. Circulation 110 (2004) 2024-2031
32. Cyrus T., Pratico D., Zhao L., Witztum J.L., Rader D.J., Rokach J., FitzGerald G.A., and Funk C.D. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice. Circulation 103 (2001) 2277-2282
33. Bocan T.M., Rosebury W.S., Mueller S.B., Kuchera S., Welch K., Daugherty A., and Cornicelli J.A. A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit. Atherosclerosis 136 (1998) 203-216
34. Benz D.J., Mol M., Ezaki M., Mori-Ito N., Zelan I., Miyanohara A., Friedmann T., Parthasarathy S., Steinberg D., and Witztum J.L. Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase. J. Biol. Chem. 270 (1995) 5191-5197
35. Havel R.J., Eder H.A., and Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34 (1955) 1345-1353
36. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
37. Basu S.K., Goldstein J.L., Anderson G.W., and Brown M.S. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 73 (1976) 3178-3182
38. Pirillo A., Norata G.D., Zanelli T., and Catapano A.L. Overexpression of inducible heat shock protein 70 in Cos-1 cells fails to protect from cytotoxicity of oxidized ldls. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 348-354
39. Schuh J., Fairclough Jr. G.F., and Haschemeyer R.H. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc. Natl. Acad. Sci. U. S. A. 75 (1978) 3173-3177
40. Han J., Nicholson A.C., Zhou X., Feng J., Gotto Jr. A.M., and Hajjar D.P. Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I. J. Biol. Chem. 276 (2001) 16567-16572
41. Yu L., Cao G., Repa J., and Stangl H. Sterol regulation of scavenger receptor class B type I in macrophages. J. Lipid Res. 45 (2004) 889-899
42. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., and Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271 (1996) 518-520
43. Bowry V.W., Stanley K.K., and Stocker R. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 10316-10320
44. Niu X., Zammit V., Upston J.M., Dean R.T., and Stocker R. Coexistence of oxidized lipids and alpha-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1708-1718
45. Cathcart M.K., and Folcik V.A. Lipoxygenases and atherosclerosis: protection versus pathogenesis. Free Radic. Biol. Med. 28 (2000) 1726-1734
46. Heydeck D., Upston J.M., Viita H., Yla-Herttuala S., and Stocker R. Oxidation of LDL by rabbit and human 15-lipoxygenase: prevalence of nonenzymatic reactions. J. Lipid Res. 42 (2001) 1082-1088
47. 3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor. J. Biol. Chem. 275 (2000) 29993-30001
48. Yancey P.G., de la Llera-Moya M., Swarnakar S., Monzo P., Klein S.M., Connelly M.A., Johnson W.J., Williams D.L., and Rothblat G.H. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J. Biol. Chem. 275 (2000) 36596-36604
49. de Beer F.C., Connell P.M., Yu J., de Beer M.C., Webb N.R., and van der Westhuyzen D.R. HDL modification by secretory phospholipase A(2) promotes scavenger receptor class B type I interaction and accelerates HDL catabolism. J. Lipid Res. 41 (2000) 1849-1857
50. Yancey P.G., Kawashiri M.A., Moore R., Glick J.M., Williams D.L., Connelly M.A., Rader D.J., and Rothblat G.H. In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux. J. Lipid Res. 45 (2004) 337-346
51. Bergt C., Reicher H., Malle E., and Sattler W. Hypochlorite modification of high density lipoprotein: effects on cholesterol efflux from J774 macrophages. FEBS Lett. 452 (1999) 295-300
52. Williams D.L., de La Llera-Moya M., Thuahnai S.T., Lund-Katz S., Connelly M.A., Azhar S., Anantharamaiah G.M., and Phillips M.C. Binding and cross-linking studies show that scavenger receptor BI interacts with multiple sites in apolipoprotein A-I and identify the class A amphipathic alpha-helix as a recognition motif. J. Biol. Chem. 275 (2000) 18897-18904
53. Bonnefont-Rousselot D., Motta C., Khalil A.O., Sola R., La Ville A.E., Delattre J., and Gardes-Albert M. Physicochemical changes in human high-density lipoproteins (HDL) oxidized by gamma radiolysis-generated oxyradicals. Effect on their cholesterol effluxing capacity. Biochim. Biophys. Acta 1255 (1995) 23-30